pirenzepine has been researched along with Cardiovascular Stroke in 3 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Excerpt | Relevance | Reference |
---|---|---|
"In patients with a recent myocardial infarction, oral pirenzepine proved equal to transdermal scopolamine in significantly increasing indexes of cardiac vagal activity." | 9.08 | Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction. ( Ballardini, L; Carù, B; Colombo, E; Pedretti, RF; Sarzi Braga, S, 1995) |
"Pirenzepine is an atropine analogue approved to treat peptic ulcer disease in Europe that is devoid of central actions, which are mostly responsible for anti-muscarinic agents side effects." | 5.32 | Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. ( Adamson, PB; Foreman, RD; Pedretti, RF; Prete, G; Vanoli, E, 2003) |
"In patients with a recent myocardial infarction, oral pirenzepine proved equal to transdermal scopolamine in significantly increasing indexes of cardiac vagal activity." | 5.08 | Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction. ( Ballardini, L; Carù, B; Colombo, E; Pedretti, RF; Sarzi Braga, S, 1995) |
"Pirenzepine is an atropine analogue approved to treat peptic ulcer disease in Europe that is devoid of central actions, which are mostly responsible for anti-muscarinic agents side effects." | 1.32 | Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade. ( Adamson, PB; Foreman, RD; Pedretti, RF; Prete, G; Vanoli, E, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pedretti, RF | 2 |
Prete, G | 1 |
Foreman, RD | 1 |
Adamson, PB | 1 |
Vanoli, E | 1 |
Colombo, E | 1 |
Sarzi Braga, S | 1 |
Ballardini, L | 1 |
Carù, B | 1 |
Engelhardt, D | 1 |
Karl, R | 1 |
Kolb, HJ | 1 |
Inthorn, D | 1 |
König, N | 1 |
Büll, U | 1 |
Hölzel, D | 1 |
2 trials available for pirenzepine and Cardiovascular Stroke
Article | Year |
---|---|
Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Baroreflex; Cross-Over Studies; Heart; Heart | 1995 |
[Comparison between cimetidine-pirenzepine and antacids for the prevention of stress hemorrhage in intensive care patients. A controlled clinical study on 125 patients].
Topics: Adult; Aged; Antacids; Benzodiazepinones; Chromium Radioisotopes; Cimetidine; Clinical Trials as Top | 1985 |
1 other study available for pirenzepine and Cardiovascular Stroke
Article | Year |
---|---|
Autonomic modulation during acute myocardial ischemia by low-dose pirenzepine in conscious dogs with a healed myocardial infarction: a comparison with beta-adrenergic blockade.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Atenolol; Dogs; Dose-Response Relationship, Dru | 2003 |